Hostname: page-component-77c89778f8-n9wrp Total loading time: 0 Render date: 2024-07-17T09:02:32.659Z Has data issue: false hasContentIssue false
  • English
  • Français

Paroxetine induced mania in pre-adolescence

Published online by Cambridge University Press:  13 June 2014

Louise Sharkey  and
Ann O'Donovan
Louise Sharkey
Affiliation:
North Eastern Health Board, Ireland
Ann O'Donovan
Affiliation:
Lucena Clinic, Dun Laoghaire, Co. Dublin, Ireland
Get access Rights & Permissions [Opens in a new window]

Abstract

Selective serotonin reuptake inhibitor induced mania has been described in adults, and more recently in adolescents. To the authors' knowledge a case in pre-adolescents has not yet been published in the literature. The authors would like to report two cases of SSRI-induced mania. Both cases were pre-adolescent girls, A and B, who had a DSM-IV diagnosis of panic disorder, and were treated with paroxetine.

Type
Case report
Information
Irish Journal of Psychological Medicine , Volume 21 , Issue 1 , March 2004 , pp. 30 - 31
Copyright
Copyright © Cambridge University Press 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Christensen, RC. Paroxetine-induced psychotic mania. Am J Psychiat 1995; 152: 1399–1400.Google ScholarPubMed
2.Oldroyd, J. Paroxetine-induced mania. J Am Acad Child Add Psychiat 1997; 36: 6: 711–21.Google ScholarPubMed
3.Vitiello, B, Behar, D, Wolfson, S, Mc Leen, SV. Diagnosis of panic disorder in prepubertal children. J Am Acad Child Adol Psychiat 1990; 29 (5): 782–4.CrossRefGoogle ScholarPubMed
4.Goldman-Rakic, CP, Brown, RM. Postnatal development of monoamine content and synthesis in the cerebral cortex of rhesus monkeys. Dev Brain Res 1982; 4: 339–49.CrossRefGoogle Scholar
5.Leonard, H, March, J, Rickler, J, Allen, AJ. Pharmacology of SSRIs in children and adolescents. J Am Acad Child Adol Psychiat 1997; 36(6): 721–2.CrossRefGoogle ScholarPubMed
6.Anderson, IM, Edwards, JG. Guidelines for choice of selectiven serotonin reuptake inhibitor in depressive illness. Adv Psychiatric Treatment 2001; 7: 170–180CrossRefGoogle Scholar
7.Achamallak, NS, Decker, DH. Mania induced by fluoxetine in an adolescent patient. Am J Psychiatry 1991; 148: 1404Google Scholar
8.Bourin, M, Coutoux, D, Tertre, A. Pharmacokinetics of psychotropic drugs in children. Clin Neuropharmacology 1992; 15 (suppl): 114–225.CrossRefGoogle ScholarPubMed
9.Findling, RL, Reed, M, Myers, C, O'Riordan, M, Fiala, S, Branicky, L, Byron, W, Blumer, J. Paroxetine pharmacokinetics in depressed children and adolescents. J Am Acad Child Adol Psychiat 1999; 38(8): 952–9.CrossRefGoogle ScholarPubMed
10.Hyman, SE, Nestler, EJ. Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am J Psychiatry 1996; 153: 151–62.Google ScholarPubMed
11.Laporta, et al.Hypomania induced by sertraline, a new serotonin reuptake inhibitor. Am J Psychiatry 1987; 144: 1513–14.Google ScholarPubMed
12.Rosenberg, DR, Johnson, K, Sahl, R. Evolving mania in an adolescent treated with low dose fluoxetine. J Child Adol Psychopharmacol 1992; 2: 299–306.CrossRefGoogle Scholar
13.Tulloch, IF, Johnson, AM. The pharmacological profile of paroxetine, a new selective serotonin reuptake inhibitor. J Clin Psychiatry 1992; 53(2, suppl) 7–12Google ScholarPubMed
14.Wilens, TE, Biederman, J, Baldessarini, RJ, Puopolo, PR, Flood, JG. Developmental changes in serum concentrations of desimipramine and 2-hydroxy-desipramine during treatment with desipramine. J Am Acad Child Adol Psychiat 1992; 31: 691–8.CrossRefGoogle Scholar